Centro Médico Jerovia S.A.
12507 - 01
Category B projects have potential environmental and/or social impacts and risks that are less adverse than those of a Category A and which are generally limited to the project site, largely reversible and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.
Projected date at which a project will be put forward for the Board of Executive Directors’ approval.
Projected board date
Duhart, Martin Javier
USD $ 100,000,000
Project scope and objective
The Project involves the construction and operation of the "Centro Médico Jerovia", a new tertiary level hospital with 175 beds (expandable to 240) to be located on a 10-hectare site owned by Centro Médico Jerovia in the city of Asunción, Paraguay, with approximately 44,983 m2 of construction that will include state-of-the-art equipment and technology. In addition, a new Prepaid Medicine company will be created whose members will be treated at the new hospital.
The cost of the project is estimated at approximately US$250 million and will be financed by a combination of equity contribution, IDB Invest debt financing (up to 40% of the project costs in the case of IDB Invest's direct participation), and third-party financing.
The Jerovia Medical Center, in partnership with Mount Sinai Hospital in New York, will offer Paraguay and the entire region a high level of medical services, infrastructure, equipment, and highly trained and qualified medical personnel for the care and well-being of the population.
For inquiries, comments and information requests about the projectRequest information
Alternatively, you may also use the following contact information:
Fernando Leri Frizza
President, Shareholder and Sponsor
IDB Invest Contact
1350 New York Ave NW, Washington, DC 20005